TIRAT CARMEL, Israel--(BUSINESS WIRE)--InSightec Ltd. today announced that it will exhibit at the 5th Annual World Health Care Congress in Washington, DC from April 21-23. The company will feature the only FDA approved MR Guided Focused Ultrasound Surgery (MRgFUS) device, the ExAblate® 2000, which has been used to treat uterine fibroids non-invasively, minimizing trauma, morbidity and recovery time. In addition to enhancing patient care, the procedure has a significant economic impact reducing overall medical costs when compared to conventional surgery. Uterine fibroid is a pervasive condition that impacts up to 70% of women of childbearing age and can lead to serious symptoms.
